Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments
June 29, 2021 16:05 ET | Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- -- Achieved Four Consecutive Quarters of Operational Profitability During Fiscal 2021 -- -- Signed...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)
May 25, 2021 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Closing of Public Offering of Common Stock
December 14, 2020 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Pricing of Public Offering of Common Stock
December 10, 2020 09:00 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Proposed Public Offering of Common Stock
December 09, 2020 16:45 ET | Avid Bioservices, Inc
TUSTIN, Ca., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
December 07, 2020 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments
December 02, 2020 16:05 ET | Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $21.1 Million -- -- Signed $28 Million in Business Orders and Ended the Quarter with a Backlog of $67 Million -- -- Initiated First Phase of Myford Expansion --...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
December 01, 2020 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020
November 24, 2020 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
September 10, 2020 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...